Synthemed Overview
- Founded
-
1990
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
1
Synthemed General Information
Description
Manufacturer of medical devices created to enhance proprietary and innovative medical products. The company's medical devices develops and commercializes proprietary bioresorbable polymer technology that addresses unmet therapeutic needs, enabling physicians to improve the level of care provided to patients of all ages.
Contact Information
Website
www.synthemed.com
Formerly Known As
Life Medical Sciences, BioMedical Polymers International
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
- 200 Middlesex Essex Turnpike
- Suite 210
- Iselin, NJ 08830
- United States
Synthemed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Synthemed Patents
Synthemed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20030007951-A1 | Applying anionic polymer; antiinflammatory agents, antiulcer agents | Abandoned | 23-Aug-2000 | 0000000000 | 00 |
| US-20020177680-A1 | Hydrolytically susceptible polyanionic polymer such as hydrogel; for example, polyethylene glcyol endcapped with one or more lactic acid groups and then acrylated; biodegradable for medical applications | Abandoned | 23-Aug-2000 | 00000000 | 00 |
| US-20010009662-A1 | Ab block polymers, comprising a polylactone part made from monomers such as lactic acid, and b is derived from hydroxyl, amine, or carboxyl terminated compound endcapped with nonreactive group; storage stablity; anti-adhesions | Granted | 11-Jul-1997 | 000000000 | 00 |
| US-6211249-B1 | Polyesterether copolymers and polurethanes and block polymers | Expired - Lifetime | 11-Jul-1997 | 000000000 | 00 |
| EP-1014998-A1 | Polymeric compositions | Granted | 11-Jul-1997 | C08G69/44 |
Synthemed Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Synthemed Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 00 | 02-Sep-2011 | 0000000 00 | Biotechnology |